Global

Healthcare Experts

Bernard Turcotte

Professor
Division of Endocrinology & Metabolism
McGill University
Canada

Biography

B.Sc. (Biology) 1981 Laval University, Québec City Ph.D. (Biochemistry) 1986 Post-doctoral fellow at the Laboratoire de Génétique moléculaire des Eucaryotes du CNRS (Université Louis Pasteur, Strasbourg, France) under Prof. Pierre Chambon's supervision (1986-1989). Post-doctoral fellow in the Department of Biology at the Massachusetts Institute of Technology (Cambridge, U.S.A.) under Prof. Leonard Guarente's supervision (1989-1992).

Research Interest

Research in my laboratory relates to functional genomics in fungi. We are focusing on a family of transcriptional regulators called zinc cluster proteins. These proteins form the most important class of transcriptional regulators in fungi. These factors regulate a large number of cellular processes including metabolism and drug resistance. However, the function of many of these factors is unknown or poorly defined. To better understand the role of these transcriptional regulators in controlling gene expression, we are using various approaches including genetics, molecular biology, as well as techniques allowing genome-wide analysis. For example, we are interested in better understanding the role of zinc cluster proteins in conferring resistance to antifungal drugs in the human fungal pathogens Candida albicans and Candida glabrata. Finally, my laboratory is interested in identifying new compounds with antifungal activity.

Publications

  • Soontorngun, N., S Baramee, C. Tangsombatvichit, P. Thepnok, S. Cheevadhanarak, F. Robert; and B. Turcotte (2012). Genome-wide location analysis reveals an important overlap between the targets of the yeast transcriptional regulators Rds2 and Adr1. Biochem. Biophys. Res. Comm. 423: 632-7

  • Clarke, M., et al. (2013) Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of pattern recognition and tyrosine kinase signalling. Genome Biology 14: R11.

  • Shah, Z, R. Mahruba and B. Turcotte (2013). The anti-cancer drug tirapazamine has antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Clostridium difficile. FEMS Microb. Lett., 347:61-9

Global Experts from Canada

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America